Efficacy and toxicity of radiotherapy for Graves' ophthalmopathy: the University of Athens experience.

Abstract

In the title compound, (C(7)H(11)N(2))(2)[SnBr(5)Cl], there is Br/Cl disorder in 0.6561 (12):0.3439 (12) and 0.8438 (12):0.1561 (12) ratios over two of three halide sites in the centrosymmetric anion, such that an overall formulation of [SnBr(5)Cl](2-) arises. In the crystal, associations of two cations and one anion linked by N-H⋯Br hydrogen bonds occur.